259 Results for "

PRMT

" in MedChemExpress (MCE) Product Catalog:
Products (259)

259 Results for "PRMT" in MCE Product Catalog:

33
33 Publications Verification
Cat. No.: HY-101563
CAS No.: 1616392-22-3
Purity:  99.51%
Synonyms: EPZ015938
GSK3326595 is a protein arginine methyltransferase 5 (PRMT5) inhibitor. GSK3326595 decreases SARS-CoV-2 infection, inhibits cancer cell proliferation and induces pro-inflammatory macrophage polarization and increases hepatic triglyceride levels without affecting atherosclerosis. GSK3326595 can be used for research of relapsed/refractory mantle cell lymphoma .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-19615B
CAS No.: 1992047-64-9
Research Areas:  

Cancer

MS023 dihydrochloride is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-19615
CAS No.: 1831110-54-3
Research Areas:  

Cancer

MS023, a chemical probe, is a potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8, respectively .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-12727
CAS No.: 1616391-65-1
Purity:  99.52%
Synonyms: GSK3235025
Research Areas:  

Cancer

EPZ015666 (GSK3235025) is an orally available inhibitor of PRMT5 with an IC50 of 22 nM.
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-128717
CAS No.: 1629013-22-4
Purity:  99.19%
Synonyms: EPZ019997
Research Areas:  

Cancer

GSK3368715 (EPZ019997) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 (EPZ019997) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-128717A
CAS No.: 1628925-77-8
Purity:  99.96%
Synonyms: EPZ019997 dihydrochloride
Research Areas:  

Cancer

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-100235
CAS No.: 1616391-87-7
Purity:  99.91%
Synonyms: EPZ015866; GSK3203591
Research Areas:  

Cancer

GSK591 (EPZ015866), a chemical probe, is a potent and selective inhibitor of protein methyltransferase 5 (PRMT5) with an IC50 of 4 nM .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-19715
CAS No.: 1687736-54-4
Research Areas:  

Metabolic Disease

SGC707, a chemical probe, is a potent, selective, and non-competitive PRMT3 (protein arginine methyltransferase 3) inhibitor (IC50=31 nM, Kd=53 nM).
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-101564
CAS No.: 2086772-26-9
Purity:  99.78%
Synonyms: JNJ-64619178
Research Areas:  

Cancer

Onametostat (JNJ-64619178) is a selective, orally active and pseudo-irreversible protein arginine methyltransferase 5 (PRMT5) inhibitor with an IC50 of 0.14 nM. Onametostat has potent activity in lung cancer .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12970
CAS No.: 1700663-41-7
Purity:  98.07%
EPZ020411 is a selective, blood-brain barrier-permeable PRMT6 inhibitor with an IC50 of 0.010 μM. EPZ020411 blocks PRMT6-mediated histone H3R2 methylation, reduces ROS production, and inhibits Apoptosis. EPZ020411 is applicable to research related to neuropathic pain, colorectal cancer, ototoxicity, hearing loss and glioblastoma .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-12970A
CAS No.: 2070015-25-5
Purity:  98.15%
EPZ020411 hydrochloride is a selective, blood-brain barrier-permeable PRMT6 inhibitor with an IC50 of 0.010 μM. EPZ020411 hydrochloride blocks PRMT6-mediated histone H3R2 methylation, reduces ROS production, and inhibits Apoptosis. EPZ020411 hydrochloride is applicable to research related to neuropathic pain, colorectal cancer, ototoxicity, hearing loss and glioblastoma .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-114965
CAS No.: 2080306-20-1
Purity:  99.61%
Research Areas:  

Inflammation/Immunology Cancer

TP-064, a chemical probe, is a potent and selective proteinarginine methyltransferase 4 (PRMT4; CARM1) inhibitor (IC50 <10 nM). TP-064 inhibits dimethylation of BAF155 (IC50 of 340 nM) and MED12 (IC50 of 43 nM). TP-064 is inactive against the other family members except for PRMT6 (IC50 of 1.3 μM). TP-064 has anticancer activities .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-18962
CAS No.: 20324-87-2
Research Areas:  

Cancer

AMI-1 is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 exerts PRMTs inhibitory effects by blocking peptide-substrate binding .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-18962A
CAS No.: 134-47-4
Research Areas:  

Cancer

AMI-1 free acid is a potent, cell-permeable and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM and 3.0 μM for human PRMT1 and yeast-Hmt1p, respectively. AMI-1 free acid exerts PRMTs inhibitory effects by blocking peptide-substrate binding .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-107777
CAS No.: 2040291-27-6
Purity:  99.22%
Research Areas:  

Cancer

LLY-283, a chemical probe, is a potent, selective and oral protein arginine methyltransferase 5 (PRMT5) inhibitor, with an IC50 of 22 nM and a Kd of 6 nM for PRMT5:MEP50 complex, and shows antitumor activity .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-112445
CAS No.: 2624313-13-7
Purity:  98.06%
Research Areas:  

Cancer

SGC3027 is a histone methyltransferase inhibitor . SGC3027 is the first potent, selective and cell active chemical probe for PRMT7 .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-110137
CAS No.: 55368-40-6
Purity:  ≥99.0%
Synonyms: DB75 dihydrochloride; NSC 305831 dihydrochloride
Furamidine dihydrochloride (DB75 dihydrochloride) is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 of 9.4 μM. Furamidine dihydrochloride is selective for PRMT1 over PRMT5, PRMT6, and PRMT4 (CARM1) (IC50s of 166 µM, 283 µM, and >400 µM, respectively). Furamidine dihydrochloride is a potent, reversible and competitive tyrosyl-DNA phosphodiesterase 1 (TDP-1) inhibitor. Inhibition of TDP-1 by Furamidine dihydrochloride is effective both with single- and double-stranded DNA substrates but is slightly stronger with the duplex DNA. Furamidine dihydrochloride is also an antiparasite agent .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-107574
CAS No.: 17328-16-4
Purity:  98.03%
TC-E 5003 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 of 1.5 µM against hPRMT1. TC-E 5003 modulates the lipopolysaccharide (LPS) (HY-D1056)-induced AP-1 and NF-κB signaling pathways with anti-inflammatory properties. TC-E 5003 also upregulates the expression of Ucp1 and Fgf21, activates protein kinase A signaling and lipolysis in primary subcutaneous adipocytes from both mouse and humans. TC-E 5003 is promising for research of obesity and associated metabolic disorders, oxidative stress, inflammation and cancers .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12759
CAS No.: 1020399-49-8
Purity:  ≥95.0%
Research Areas:  

Cancer

CARM1-IN-1 (compound 7g) is a highly potent and selective inhibitor of CARM1 (IC50=8.6 μM, CARM1/PABP1), with low inhibitory activity against PRMT1 and SET7 (IC50 >667 μM). CARM1-IN-1 inhibits the methylation activity of CARM1 and the methylation levels of different substrates, such as PABP1, CA150, SmB, and H3. CARM1-IN-1 also inhibits the promoter activity of prostate-specific antigen (PSA) without significant cytotoxicity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12759A
CAS No.: 2070018-31-2
Purity:  95.13%
Research Areas:  

Cancer

CARM1-IN-1 (compound 7g) hydrochloride is a highly potent and selective inhibitor of CARM1 (IC50=8.6 μM, CARM1/PABP1), with low inhibitory activity against PRMT1 and SET7 (IC50 >667 μM). CARM1-IN-1 hydrochloride inhibits the methylation activity of CARM1 and the methylation levels of different substrates, such as PABP1, CA150, SmB, and H3. CARM1-IN-1 hydrochloride also inhibits the promoter activity of prostate-specific antigen (PSA) without significant cytotoxicity .
loading...
    loading...